MYCN and neoplasm: Applying these gene signatures to the NB tumour data, we found that expression signatures C5* (sensory neuron-like cells) and C13* (differentiating SYM-like cells), jointly separated MYCN-amplified and non-amplified tumours, as well as tumours at different clinical stages (Fig. 7d).